The pill is expected to treat breast cancer

In the 2016-03-01 s when

Source: changzhou daily

Xinhua kunming on February 29 (xinhua yue rising) breast cancer is the leading cause of cancer incidence in women. A few days ago, the scientists found that the pill has inhibitory effect on breast cancer, mifepristone three negative breast cancer can be used as an effective candidate drugs, the study results in the recently published in international journals in diagnostics of treatment.

According to the paper, the authors of the Chinese academy of sciences in kunming animal research institute researcher at the third, points four types of breast cancer, respectively is: cavity epithelial type a, type b cavity epithelium, human epidermal growth factor (positive) and three Yin. Among them, the most vicious are three negative breast cancer. Because of the lack of specific therapeutic targets and targeted therapy method, three negative breast cancer has become a difficulty and a focus of breast cancer research.

Real researchers led by the Chinese academy of sciences in kunming animal Chen Ce tumor biology discipline group after the previous research found that mifepristone can well restrain three negative breast cancer cell lines and anthropogenic negative breast cancer in immunocompromised mice transplanted tumor growth. Further research also shows that three negative breast cancer cells induced by mifepristone, a tiny RNA - 153 (mir - 153), thus promoting the proliferation inhibition in breast cancer, survival, and cell regulatory protein (klf5) expression of dry, thus inhibiting the three negative breast cancer stem cells maintain and update.